News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Aditi Singh: A pretty pretty, pretty good news ASCO24
Photo taken from Aditi Singh/X
Apr 5, 2024, 16:26

Aditi Singh: A pretty pretty, pretty good news ASCO24

Aditi Singh, Thoracic Oncology Fellow at Mayo Clinic, made the following post on X:

“A pretty pretty, pretty good news ASCO24, Ahmed Abdalla, Arthi Sridhar.
-1 first author poster presentation
-1 second author poster presentation.”

Source: Aditi Singh/X

Aditi Singh Ahmed Abdalla Arthi Sridhar ASCO24 cancer Oncology Research
Special Coverage
Insight
Jan 23, 2025, 09:49
Angela Mastronuzzi: Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
Insight
Jan 23, 2025, 09:45
Leah Naghi: Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing
Insight
Jan 23, 2025, 09:43
Amol Akhade: Intresting results on subcutaneous Amivantamab in CRC
Blog
Jan 23, 2025, 09:41
Applications are open for the CCI4EU Second Capacity Building Conference - OECI
Blog
Jan 23, 2025, 09:39
Sendurai Mani: The Scientific Journey of Robert Weinberg
Blog
Jan 23, 2025, 09:37
Experiences and challenges of young adult patients with CRC - Dana-Farber Cancer Institute
Insight
Jan 23, 2025, 09:32
Scientific Insights from Prof. Hope Rugo: Advancements in Metastatic HER2+ Breast Cancer Therapy
Blog
Jan 23, 2025, 09:26
Rajkumar Venkatramani: I crossed the finish line at the Houston Half Marathon
Career
Jan 23, 2025, 09:22
Nirali Shah was elected to the American Society of Clinical Investigation - NCI Center for Cancer Research
Blog
Jan 23, 2025, 09:09
Sean Khozin: Grateful to have joined the Richard Nixon Foundation Cancer Conference
Insight
Jan 23, 2025, 09:08
How Egypt is closing the gap in breast cancer care: Dr. Hesham El-Ghazaly leads the conversation
Blog
Jan 23, 2025, 09:06
David Lee: Staying true to our purpose at Servier Pharmaceuticals